Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_917_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
32 Мб
Скачать
4 Master Program Colorectal Pathway: Laparoscopic Splenic Flexure Release (Tips…
55
traction do not occur. The most common mechanism whereby the spleen is injured during splenic mobilization involves excessive pulling on the descending or trans­verse colon when the greater omentum is attached to the splenic capsule. The result is avulsion of capsule and subsequent bleeding. When this occurs, generally the best approach is to pack the area and wait for hemostasis rather than resort to more aggressive strategies. That being said, clearly the best way to treat a splenic injury is to avoid it in the rst place [19].
Other areas of risk involve injury to the pancreas, particularly in the area of the splenic hilum and the pancreatic tail. While mobilizing the splenic exure, one must be certain to be anterior to the tail of the pancreas and away from the splenic hilum. It is not difcult when fully mobilizing the mesentery of the distal transverse colon and the proximal descending colon to delve too deep into the retroperitoneum and inadvertently dissect posterior to the pancreatic tail. This, in turn, takes the surgeon into the splenic hilum [19].
Lastly, a potential complication, which is unique to the inframesocolic approach, includes carrying the dissection at the IMV to posterior and coming underneath the inferior border of the pancreas. The real problem here is that if this is continued, one can enter the splenic vein, which could result in major bleeding. By recognizing this possibility, the surgeon should be able to avoid this issue entirely.
The inframesocolic approach is more difcult to adopt from a technical stand­point. It is the preferred approach during robotic dissection, when changes in table positioning are much more restricted. It is our recommendation that surgeons become facile with all three approaches. But while learning each technique, the surgeon should be aware of the limitations and risks of each approach and have a low threshold to convert to another approach or to an open approach.
Another area of difculty that can be encountered is when the greater omentum is so prominent that it either entirely obscures the exure and/or is densely fused with the mesentery (Fig.4.10). This needs to be carefully released to obtain ade­quate length that can be carried out for a safe colorectal anastomosis.
Fig. 4.10 Greater
omentum covering the splenic exure
56
A. Caycedo-Marulanda and J. H. Marks

Outcomes

Literature comparing different approaches for SFR is scarce. Perhaps the most signicant publication is from Benseler and colleagues. This retrospective study compared the use of the three different approaches on 303 patients that underwent laparoscopic surgery for rectal cancer at a single center over a 12-year period. The authors identied a signicantly higher rate of intraoperative complications (p=0.038), including dissecting in the wrong plane, organ injury, and bleeding, for those patients that had SFR using the lateral approach. Postoperative morbidity was also higher on the same group, secondary to increased wound infection (p=0.001) [20]. We cannot provide any rational explanation for these results nor would we allow this to factor into our decision-making for how to best approach this operative step.

Conclusions

Splenic exure release is an integral part of the procedure for a multitude of colon surgeries. The general and colorectal surgeon must be entirely comfortable with the different approaches in order to carry this out in a routine fashion. In most cases, the splenic exure can be released by using one of the above-described techniques. However, on occasion, a combination of approaches is required. We recommend that each surgeon develop their preferred technique which they use routinely but also become facile with the other approaches as these will be helpful at times, and it is best to be knowledgeable before trying a technique in a difcult situation.
We advocate the routine release of the splenic exure for a safe anastomosis. It is the authors’ opinion that consideration to releasing the splenic exure be given early on during the procedure in a proactive fashion, rather than reserving it for when it is necessary in order to achieve adequate length for the anastomosis. Delaying the decision to complete splenic exure takedown until the end of an oth­erwise difcult operation can complicate the procedure even further. Routine release using a standardized approach will result in better outcome for patients with colorec­tal disease.

References

1. Goulder F. Bowel anastomoses: the theory, the practice and the evidence base. WJGS.
2012;4(9):208–6.
2. Chand M, Miskovic D, Parvaiz AC.Is splenic exure mobilization necessary in laparoscopic
anterior resection? Dis Colon Rectum. 2012;55(11):1195–7.
3. Brennan DJ, Moynagh M, Brannigan AE, Gleeson F, Rowland M, OʼConnell RP. Routine
mobilization of the splenic exure is not necessary during anterior resection for rectal cancer. Dis Colon Rectum. 2007;50(3):302–7.
4. Tortorelli A, Aleri S, Sanchez A, Rosa F, Papa V, Di Miceli D, et al. Anastomotic leakage
after anterior resection for rectal cancer with mesorectal excision: incidence, risk factors, and management. Am J Surg. 2015;81(1):41–7.
4 Master Program Colorectal Pathway: Laparoscopic Splenic Flexure Release (Tips…
5. Toh JWT, Matthews R, Kim SH.Arc of Riolan-preserving splenic exure takedown during
anterior resection. Dis Colon Rectum. 2018;61(3):411–4.
6. Jurowich CF, Germer CT.Elective surgery for sigmoid diverticulitis– indications, techniques,
and results. Visc Med. 2015;31(2):112–6.
7. Rullier E, Denost Q, Vendrely V, Rullier A, Laurent C.Low rectal cancer. Dis Colon Rectum.
2013;56(5):560–7.
8. Marks JH, Myers EA, Zeger EL, Denittis AS, Gummadi M, Marks GJ. Long-term out-
comes by a transanal approach to total mesorectal excision for rectal cancer. Surg Endosc. 2017;31(12):5248–57.
9. Marks JH, Salem JF.From TATA to NOTES: how taTME ts into the evolutionary surgical
tree. Tech Coloproctol. 2016;20(8):513–5.
10. Marks JH, Montenegro GA, Salem JF, Shields MV, Marks GJ.Transanal TATA/TME: a case-
matched study of taTME versus laparoscopic TME surgery for rectal cancer. Tech Coloproctol. 2016;20(7):467–73.
11. Caycedo-Marulanda A, Ma G, Jiang HY. Transanal total mesorectal excision (taTME)
in a single- surgeon setting: renements of the technique during the learning phase. Tech Coloproctol. 2018;22(6):433–43.
12. Fukuoka A, Sasaki T, Tsukikawa S, Miyajima N, Ostubo T. Evaluating distribution of
the left branch of the middle colic artery and the left colic artery by CT angiography and colonography to classify blood supply to the splenic exure. Asian J Endosc Surg. 2016;10(2):148–53.
13. Sakorafas GH, Zouros E, Peros G.Applied vascular anatomy of the colon and rectum: clinical
implications for the surgical oncologist. Surg Oncol. 2006;15(4):243–55.
14. Kawamoto A, Inoue Y, Okigami M, Yasuda H, Okugawa Y, Hiro J, etal. Preoperative assess-
ment of vascular anatomy by multidetector computed tomography before laparoscopic colec­tomy for transverse colon cancer: report of a case. Int Surg. 2015;100(2):208–12.
15. McDermott S, Deipolyi A, Walker T, Ganguli S, Wicky S, Oklu R.The role of preoperative
angiogram in colon interposition surgery. Diagn Interv Radiol. 2012;18(3):314–8.
16. Takeru M, Takeshi I, Kenro H, Daisuke T, Yutaka S, Yasuo S, et al. A three-step method for
laparoscopic mobilization of the splenic exure. Ann Surg Oncol. 2015;22(s335):1–1.
17. Garcia-Granero A, Sánchez-Guillén L, Carreño O, Sancho Muriel J, Alvarez Sarrado
E, Fletcher Sanfeliu D, et al. Importance of the Moskowitz artery in the laparoscopic medial approach to splenic exure mobilization: a cadaveric study. Tech Coloproctol. 2017;21(7):567–72.
18. Blanco-Colino R, Espin-Basany E.Intraoperative use of ICG uorescence imaging to reduce
the risk of anastomotic leakage in colorectal surgery: a systematic review and meta-analysis. Tech Coloproctol. 2017;22(1):15–23.
19. Merchea A, Dozois EJ, Wang JK, Larson DW.Anatomic mechanisms for splenic injury during
colorectal surgery. Clin Anat. 2011;25(2):212–7.
20. Benseler V, Hornung M, Iesalnieks I, Breitenbuch von P, Glockzin G, Schlitt HJ, etal. Different
approaches for complete mobilization of the splenic exure during laparoscopic rectal cancer resection. Int J Color Dis. 2012;27(11):1521–9.
57
Bibliography
Atallah S, Albert M, Monson JRT.Critical concepts and important anatomic landmarks encoun-
tered during transanal total mesorectal excision (taTME): toward the mastery of a new opera-
tion for rectal cancer surgery. Tech Coloproctol. 2016;20(7):483–94. Deijen CL, Tsai A, Koedam TWA, Veltcamp Helbach M, Sietses C, Lacy AM, etal. Clinical out-
comes and case volume effect of transanal total mesorectal excision for rectal cancer: a system-
atic review. Tech Coloproctol. 2016;20(12):811–24.
58
Koedam TWA, van Ramshorst GH, Deijen CL, Elfrink AKE, Meijerink WJHJ, Bonjer HJ, etal.
Transanal total mesorectal excision (TaTME) for rectal cancer: effects on patient-reported
quality of life and functional outcome. Tech Coloproctol. 2017;21(1):25–33. Lee L, De Lacy B, Gomez Ruiz M, Liberman AS, Albert MR, Monson JRT, etal. A multicenter
matched comparison of transanal and robotic total mesorectal excision for mid and low-rectal
adenocarcinoma. Ann Surg. 2018; https://doi.org/10.1097/SLA.0000000000002862. [Epub
ahead of print] Pasam RT, Trejo DE, Murray A, Lee-Kong S, Feingold D, Kiran RP. PTU-223 Conversion
to open surgery from laparoscopy: to ‘try and fail’ or ‘not try at all’? Gut. 2015;64(Suppl
1):A161.1–A161.
Sylla P, Rattner DW, Delgado S, Lacy AM.NOTES transanal rectal cancer resection using trans-
anal endoscopic microsurgery and laparoscopic assistance. Surg Endosc. 2010;24(5):1205–10. Wong-Chong N, Caycedo-Marulanda A. Transanal total mesorectal excision with retroileal
colorectal anastomosis: combining old and new techniques. Color Dis. 2018;20(7):642–3.
A. Caycedo-Marulanda and J. H. Marks
Masters Program Colorectal Pathway: Laparoscopic Left Colon Resection forComplex Inflammatory Bowel Disease
AnuradhaR.Bhama andConorP.Delaney
Introduction andRationale
Crohn’s disease can be a challenging disease process for surgeons to treat. Patients often present with obstruction, an abscess, or stula, frequently with septic compli­cations of their disease [1]. When possible, these are initially treated nonoperatively with image-guided drainage procedures and antibiotics in order to stabilize the patient and clear the sepsis. This then allows for time to hold immunosuppressive medications and optimize nutritional parameters to allow for an elective resection. Less frequently, nonoperative preparation and preoperative optimization may not be possible, and the patient will require a more emergent operative procedure. This is usually related to intestinal obstruction or perforation of a previously contained abscess.
This chapter will focus on the specic considerations regarding stula and abscess necessary in patients with CD.Fistulas can occur between the small bowel and colon with any adjacent structure including the bladder, the vagina, other gas­trointestinal sites, or, more rarely, the skin (Figs. 5.1a, b and 5.2). In situations involving a stula between the left colon and the small intestine, it is necessary to determine the segment of the diseased intestine that is the origin of the stula, as the diseased segment is the portion of the bowel that should be resected. If the small intestine is diseased, then frequently only the small intestine requires resection, pro­vided the sigmoid colon is free of disease and the stulous opening is small and amenable to primary repair, as described below (Figs.5.3, 5.4, 5.5, and 5.6a–c). Regardless, a laparoscopic approach can usually be utilized safely to perform a
5
A. R. Bhama Department of Surgery, Division of Colorectal Surgery, Rush University Medical Center, Chicago, IL, USA
C. P. Delaney ( Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, OH, USA e-mail: delanec@ccf.org
© Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) 2020 P. Sylla et al. (eds.), The SAGES Manual of Colorectal Surgery,
https://doi.org/10.1007/978-3-030-24812-3_5
*)
59
60
A. R. Bhama and C. P. Delaney
ab
Fig. 5.1 (a, b) Examples of colocutaneous stula in patients with inammatory bowel disease
Fig. 5.2 CT scan of
patient with colovesical stula. Note air in the bladder
Fig. 5.3 Fistula between
healthy small bowel and diseased segment of colon
ab
5 Masters Program Colorectal Pathway: Laparoscopic Left Colon Resection…
Fig. 5.4 Luminal view of
enteric stula in setting of active inammatory Crohn’s disease
61
Fig. 5.5 (a, b) Laparoscopic views of stulizing Crohn’s disease
left-sided colon resection in most situations [2, 3]. Some patients with chronic com­plex diverticular disease may present with stulas and abscesses that require similar management [4].
Indications andContraindications
A laparoscopic approach is indicated in almost all patients. Inability to tolerate pneumoperitoneum and steep Trendelenburg position because of medical comor­bidity or massive obesity are rare in this population. The primary contraindication is a prior history of multiple surgeries with obliterative adhesions. Anatomical con­siderations that may complicate laparoscopy include large hernias, dense adhesions from prior surgery, or enterocutaneous stulas that require resection of the abdomi­nal wall. Patients who are hemodynamically unstable generally cannot tolerate lapa­roscopy, as the positioning is typically more exaggerated, the operative times may be longer, and the pneumoperitoneum causes a decrease in cardiac preload. Patients
62
A. R. Bhama and C. P. Delaney
a
b
c
Fig. 5.6 (a–c) Crohn’s ileosigmoid stula. After conrming that the sigmoid is not primarily
involved with active inammatory Crohn’s disease, the endoscopic stapler is used to transect across the stula followed by resection of the disease terminal ileum and preservation of the sig­moid colon. (All: Courtesy of Daniel Popowich, MD)
must be able to tolerate the physiologic changes associated with laparoscopy in order to undergo this approach. This includes patients with severe pulmonary dis­ease as well. In the vast majority of cases, however, laparoscopy can be attempted and if the patient does not tolerate a trial at positioning, or adhesions are too severe, conversion to an open procedure may be indicated. Other contraindications include lack of surgeon experience or lack of appropriate equipment.
There are some situations in which a large stula is present that may require assistance from other subspecialty surgeons, such as a low bladder stula or rare ureteric stula. In such cases, it is necessary to coordinate preoperative planning with the assisting surgeons. Especially for the sigmoid colon, if it is possible to do the majority of the procedure laparoscopically and a portion of the procedure through a small Pfannenstiel incision, many of the benets of laparoscopy may be provided to the patient by minimizing the size of the denitive incision. Careful preoperative planning in a team-based approach and clear communication with the operating room staff is necessary in these situations.
Segmental colon resection in the setting of CD remains somewhat controversial [510]. Although a full discussion of this topic is outside the connes of this chap­ter, a total colectomy is usually indicated for CD-related dysplasia or pancolitis, considering ileorectal anastomosis for those with rectal sparing and good conti­nence [11]. Segmental colectomy, with or without a temporary diverting ileostomy, can be considered for those with short segment disease in whom the rectum, anus, and proximal colon appear salvageable.
5 Masters Program Colorectal Pathway: Laparoscopic Left Colon Resection…
63
Principles andQuality Benchmarks
The rst principle of treating IBD associated with stula and abscess is to ensure that the source of sepsis has been controlled, and the patient has been stabilized hemodynamically. These patients rarely present acutely. When possible, treatment with antibiotics and utilization of radiologic drainage as a bridge to surgery is advo­cated to clear sepsis and allow the patient to recover from systemic sepsis and allow for preoperative optimization. Nutritional optimization may need to be considered as well, and we primarily base assessment on weight loss, using prealbumin in those otherwise suspected to be malnourished. Patients are frequently evaluated by dieti­cians on the multidisciplinary team. If patients can tolerate enteral diets, they are educated on dietary choices and supplements that optimize their protein and calorie needs. If patients cannot tolerate oral intake, they are evaluated and followed care­fully by members of a multidisciplinary nutritional support team to manage enteral or total parenteral nutrition. Ideally patients will demonstrate weight gain or stabili­zation of weight loss and normal serum markers of nutrition including albumin and prealbumin. There are instances where the disease severity is so great that surgical resection is necessary prior to improvement in nutritional status. For that reason, we generally are more concerned about getting 7–10days of adequate nutrition, rather than waiting for laboratory values to normalize.
When proceeding with the operation, it is important to remember to evaluate the entire bowel for active disease, even if the indication for operation is colonic dis­ease. The extent of disease is not always accurately identied preoperatively. Typically, preoperative evaluation includes colonoscopy and one or more means of small bowel assessment, such as CT or MR enterography. If no recent endoscopic assessment is available, preoperative colonoscopy should be performed to assess for the extent of colitis or proctitis and for any underlying malignancy, as it allows more accurate surgical planning and a better discussion with the patient. If patients are very symptomatic and/or preoperative colonoscopy cannot be completed, this can be performed intraoperatively. Even so, it is important to visually inspect the entire intestine for active disease and in our practice, we generally exteriorize and “run” or sequentially palpate the entire small intestine. At a minimum this can be done lapa­roscopically with a hand-over-hand technique of running the small bowel, with care taken to avoid injuring the bowel, although generally the small bowel can be exteri­orized and palpated when a specimen is being removed.
When performing a resection for CD, it is important to preserve as much bowel as possible, though this is less directly relevant for colonic disease. Surgical margins should be grossly negative for active disease for 2cm, as dened by the normal appearing bowel with absence of mesenteric inammation. It is not necessary to have frozen section assessment of surgical margins. An anastomosis should not be created if there is active purulence in proximity to the anastomosis, such as a large pelvic abscess with resultant thickening and secondary inammation of the distal rectum. A proximal diverting loop ileostomy should be considered if there are con­cerns about the quality of the remaining intestine for anastomosis, patient nutrition, or immunosuppression.
64
A. R. Bhama and C. P. Delaney
Preoperative Planning, Patient Workup, andOptimization
Except in the relatively rare situations of bleeding or acute perforation, preoperative optimization is essential for patients with IBD.Abscesses that can be drained are dealt with using image-guided techniques, including retroperitoneal abscesses, unless small. Smaller abscesses and some intramesenteric abscesses may be best left undrained and treated with antibiotics. Holding any immunosuppressive agents, such as biologic agents, is also recommended. Steroids are tapered if possible but can rarely be stopped in patients with these types of symptoms. There are no set guide­lines for the duration of time of biologic agents to be held, though we generally wait 6–8weeks prior to proceeding with an operation. The nutritional status of the patient should be assessed to determine the safety of proceeding with an operation and the likelihood of successful healing postoperatively. Evaluation of serum levels of albu­min, prealbumin, and transferrin is useful. In patients who are malnourished, preop­erative supplemental nutrition may be necessary. This can be done orally with high-protein supplements but may require enteral or parenteral nutrition, particularly in those who are chronically partially obstructed with their disease, or who have high-output or symptomatic stulas which preclude intestinal feeding. Postoperative supplemental enteral or parenteral nutrition is generally unnecessary. Many patients are also routinely seen by our enterostomal team and given a temporary mark for a stoma. In cases requiring intraoperative decision-making, both left and right-sided marks are placed, taking care to be away from old scars and skinfolds.
Once surgery is scheduled, standard enhanced recovery protocols are applied [12]. Patients should be encouraged to stop smoking and limit alcohol intake, as these have been shown to have improved postoperative outcomes when done for greater than 4weeks prior to operation. Patient education and setting clear postop­erative expectations are paramount in preparation for surgery. This discussion includes expected goals regarding pain control, postoperative diet advancement, patient participation in recovery, and discharge criteria and planning.
In preparation for the operation, all patients who are not obstructed should undergo mechanical bowel preparation. Bowel preparation is commonly utilized as it provides several benets in the laparoscopic setting. The decompressed bowel after mechanical bowel preparation allows for easier manipulation and specimen extraction. Particularly important is that the addition of oral neomycin and metroni­dazole with the mechanical bowel appears to be associated with a signicant decrease in rate of postoperative surgical site infection.
Preoperative diet remains controversial, as patients traditionally fast from mid­night the night prior to surgery. In our practice, consistent with anesthesia guidelines, patients are allowed to continue to consume clear liquids up until 2hours prior to surgery. Some enhanced recovery protocols also provide patients with carbohydrate loading uids to drink the morning of surgery. Patients with chronic obstructive dis­ease who will not tolerate a bowel preparation are kept on a liquid diet for 48hours and given two bottles of magnesium citrate, a milder preparation that is usually toler­ated reasonably well. For more details on preoperative preparations, please refer to the chapters on enhanced recovery protocols in colorectal surgery (Chaps. 7 and 8).